Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TECH | Common Stock | Options Exercise | +2.26K | +1673.33% | 2.39K | Apr 3, 2024 | Direct | F1 | ||
transaction | TECH | Common Stock | Tax liability | -$50.7K | -747 | -31.2% | $67.87 | 1.65K | Apr 3, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TECH | Restricted Stock Units | Options Exercise | $0 | -2.26K | -33.33% | $0.00 | 4.52K | Apr 3, 2024 | Common Stock | 2.26K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. |
F2 | 2,260 restricted stock units vest on 4/3/25 and 2,259 restricted stock units vest on 4/3/26. |